Agronomic portal Agronom.info
Categories
Language
Currency
My account
Rapeseed

Azurit

Diseases
Alternariosis, Verticillosis, Viruses, Rot, Phomosis
Country
France
Registration Year
2022
Manufacturer
RAGT
Offers: 8
Where to buy
Price range
572.92 - 8 990 UAH
Views
4
Reviews
0
Producer
RAGT
Description Azurit
Azurite is a mid-late winter rapeseed hybrid developed by the breeding company RAGT. It is characterized by high winter hardiness and is adapted to modern agricultural technologies, ensuring stable autumn development and effective spring regeneration. Thanks to these qualities, Azurite is suitable for sowing both early and late, expanding its cultivation possibilities in various climatic conditions.

The hybrid exhibits high resistance to major rapeseed diseases, including phomopsis, white mold, alternaria, and verticillium, as well as to turnip yellow vein virus (TuYV). In addition, it demonstrates excellent resistance to lodging and seed cracking, which helps preserve yield and improve product quality. Azurite also features high cold and drought tolerance, making it a reliable choice for cultivation in the Polissia, Forest-Steppe, and Steppe regions of Ukraine.

The hybrid's yield potential reaches 60 centners per hectare at a seeding rate of 35–45 plants per square meter. Seeds are supplied in packages of 1.5 million, convenient for large-scale agricultural production. High oil content and balanced agronomic characteristics make Azurite attractive to farmers seeking high-quality and stable rapeseed yields.
Specifications Azurit
Diseases
Alternariosis
Alternariosis
Verticillosis
Verticillosis
Viruses
Yellowing and leaf curl viruses
Rot
Rots
Phomosis
Phomosis
Type of Rape
Winter rape
Hybrid Type
Simple Linear
Yield Potential
60-70 ц/га
Number of plants per hectare
500 thousand pcs/ha
600 thousand pcs/ha
700 thousand pcs/ha
800 thousand pcs/ha
900 thousand pcs/ha
Country
France
Registration Year
2022
Catalog
Varieties
Technical Crops
Manufacturer
RAGT
Where to buy Azurit
Loading...
Reviews Azurit
0comments
Sort by:Popular first
No comments yet.